Theravance Biopharma Inc TBPH インサイダー取引

Theravance Biopharma Inc (TBPH) インサイダー取引

フィルター:

日付	保有者名	取引株数	金額レンジ ($)	取引種別	価格レンジ ($)	届出終了時の株数	% 変化
2026-06-29	Madison Avenue Partners, LP法人	-336.70k	5.79M	売り	17.00 - 17.23	9.17M	-3.54%
2026-06-15	Ms. Rhonda F. FarnumChief Business Officer and Senior VP of Commercial & Medical Affairs	-13.31k	218.17k	Automatic Disposition	16.38 - 16.39	232.46k	-5.42%
2026-05-20	Mr. Rick E. WinninghamCEO & Director	-20.04k	331.63k	Sale to Issuer	16.55	1.75M	-1.13%
2026-05-20	Mr. Aziz SawafSenior VP of Operations Strategy & CFO	-8.67k	143.49k	Sale to Issuer	16.55	344.95k	-2.45%
2026-05-20	Dr. Aine MillerSenior VP of Development & Head of Ireland Office	-6.83k	112.99k	Sale to Issuer	16.55	177.33k	-3.71%
2026-05-20	Mr. Brett A. GrimaudSenior VP, General Counsel & Secretary	-8.83k	146.12k	Sale to Issuer	16.55	363.12k	-2.37%
2026-05-20	Ms. Rhonda F. FarnumChief Business Officer and Senior VP of Commercial & Medical Affairs	-5.68k	93.97k	Sale to Issuer	16.55	245.77k	-2.26%
2026-03-16	Ms. Rhonda F. FarnumChief Business Officer and Senior VP of Commercial & Medical Affairs	-31.07k	433.64k	Automatic Disposition	13.92 - 14.00	232.70k	-11.78%
2026-02-20	Mr. Rick E. WinninghamCEO & Director	-74.98k	1.47M	Sale to Issuer	19.66	1.69M	-4.24%
2026-02-20	Mr. Aziz SawafSenior VP of Operations Strategy & CFO	-20.67k	406.41k	Sale to Issuer	19.66	316.12k	-6.14%
2026-02-20	Dr. Aine MillerSenior VP of Development & Head of Ireland Office	-16.85k	331.29k	Sale to Issuer	19.66	184.16k	-8.38%
2026-02-20	Mr. Brett A. GrimaudSenior VP, General Counsel & Secretary	-20.83k	409.58k	Sale to Issuer	19.66	334.45k	-5.86%
2026-02-20	Ms. Rhonda F. FarnumChief Business Officer and Senior VP of Commercial & Medical Affairs	-13.93k	273.84k	Sale to Issuer	19.66	263.77k	-5.02%
2025-12-03	Ms. Rhonda F. FarnumChief Business Officer and Senior VP of Commercial & Medical Affairs	-31.07k	582.50k	Automatic Disposition	18.75	277.70k	-10.06%
2025-11-26	Mr. Eran Broshyインサイダー	-29.50k	590.02k	Automatic Disposition	20.00	34.05k	-46.42%
2025-11-20	Mr. Aziz SawafSenior VP of Operations Strategy & CFO	-18.63k	333.42k	Sale to Issuer	17.90	336.80k	-5.24%
2025-11-20	Dr. Aine MillerSenior VP of Development & Head of Ireland Office	-6.99k	125.10k	Sale to Issuer	17.90	201.01k	-3.36%
2025-11-20	Mr. Brett A. GrimaudSenior VP, General Counsel & Secretary	-19.02k	340.53k	Sale to Issuer	17.90	355.28k	-5.08%
2025-11-20	Ms. Rhonda F. FarnumChief Business Officer and Senior VP of Commercial & Medical Affairs	-9.06k	162.17k	Sale to Issuer	17.90	308.76k	-2.85%
2025-11-20	Mr. Rick E. WinninghamCEO & Director	-56.82k	1.02M	Sale to Issuer	17.90	1.77M	-3.12%
2025-11-19	Mr. Rick E. WinninghamCEO & Director	-9.90k	0.00	Other Disposition	-	1.77M	-0.56%
2025-11-11	Mr. Eran Broshyインサイダー	-45.00k	809.25k	Automatic Disposition	17.00 - 18.50	49.56k	-47.59%
2025-08-20	Mr. Rick E. WinninghamCEO & Director	-15.39k	206.13k	Sale to Issuer	13.39	1.82M	-0.84%
2025-08-20	Mr. Aziz SawafSenior VP of Operations Strategy & CFO	-9.37k	125.44k	Sale to Issuer	13.39	355.42k	-2.57%
2025-08-20	Dr. Aine MillerSenior VP of Development & Head of Ireland Office	-6.99k	93.58k	Sale to Issuer	13.39	208.00k	-3.25%
2025-08-20	Mr. Brett A. GrimaudSenior VP, General Counsel & Secretary	-9.76k	130.71k	Sale to Issuer	13.39	374.31k	-2.54%
2025-08-20	Ms. Rhonda F. FarnumChief Business Officer and Senior VP of Commercial & Medical Affairs	-9.10k	121.80k	Sale to Issuer	13.39	317.82k	-2.78%
2025-07-14	Ms. Rhonda F. FarnumChief Business Officer and Senior VP of Commercial & Medical Affairs	-10.00k	113.87k	Automatic Disposition	11.39	326.92k	-2.97%